INDEGENE
|
The Current P/B Ratio of INDEGENE is 9.55.
Share Price | ₹556.1 | Apr 04,2025 |
Market Cap | ₹13,346.4 Cr | |
Book Value | ₹1,397.7 Cr | Mar2024 - Consolidated Results |
Price/Book | 9.55x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,346.4 Cr] as on Apr 04,2025
(/) Book Value [ ₹1,397.7 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 9.55x ]
Thus, for INDEGENE , the investors are currently willing to pay '9.55 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 1,397.70 | 9.55 | 13,346.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.44 | 410,142.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 10.74 | 145,762.0 |
CIPLA LTD | 26,619.90 | 4.29 | 114,322.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.21 | 111,171.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.29 | 92,603.7 |
MANKIND PHARMA LTD | 9,339.84 | 10.82 | 101,098.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.40 | 87,205.3 |
LUPIN LTD | 14,175.80 | 6.35 | 89,993.5 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.15 | 64,167.0 |
ABBOTT INDIA LTD | 3,658.73 | 16.87 | 61,727.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.15x |
Max industry PB | 16.87x |
Median industry PB | 6.44x |
Average industry PB | 8.28x |
You may also like the below Video Courses